Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective.
Ennio LubranoSilvia ScriffignanoFabio Massimo PerrottaPublished in: Rheumatology and therapy (2022)